These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


137 related items for PubMed ID: 4408061

  • 21. Long-term follow-up of two chemotherapy protocols in Hodgkin's disease.
    Pavlovsky S, Morgenfeld M, Somoza N, Magnasco J, Sackmann Muriel F, Cavagnaro F, Suárez A, Barros CA, Saslavsky J, Garay G, Palau M, Besuschio SC.
    Medicina (B Aires); 1981; 41 Suppl():15-21. PubMed ID: 6896551
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Childhood Hodgkin disease treated with COPP/ABV hybrid chemotherapy: a progress report.
    Sagar TG, Chandra A, Raman SG.
    Med Pediatr Oncol; 2003 Jan; 40(1):66-9. PubMed ID: 12426693
    [No Abstract] [Full Text] [Related]

  • 24. [Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV].
    Lopez M.
    Clin Ter; 2001 Jan; 152(3):203-6. PubMed ID: 11692542
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Combination chemotherapy of advanced Hodgkin's disease.
    Gray JL, Robinson WA.
    Rocky Mt Med J; 1973 Oct; 70(10):33-7. PubMed ID: 4748111
    [No Abstract] [Full Text] [Related]

  • 27. Current chemotherapeutic combinations.
    DeVita VT, Carbone PP.
    Ser Haematol; 1973 Oct; 6(2):182-95. PubMed ID: 4593779
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Chemotherapeutic implications of staging in Hodgkin's disease.
    DeVita VT, Carbone PP.
    Cancer Res; 1971 Nov; 31(11):1838-44. PubMed ID: 4941352
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients].
    Andrieu JM, Casassus P, Coscas Y, Darmont J, Goubeau C, Katz M, Jacquillat C, Tricot G, Weil M.
    Bull Cancer; 1982 Nov; 69(4):321-9. PubMed ID: 6897520
    [No Abstract] [Full Text] [Related]

  • 34. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH, Wang SS, Huang Y, Wang B, Huang HQ, Zhang L, Sun XF, Xu RH, Lin TY.
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Eastern cooperative oncology group studies.
    Lenhard RE.
    Arch Intern Med; 1973 Mar; 131(3):418-20. PubMed ID: 4688039
    [No Abstract] [Full Text] [Related]

  • 38. Splenectomy effects on chemotherapy in Hodgkin's disease.
    Panettiere F, Coltman CA.
    Arch Intern Med; 1973 Mar; 131(3):362-6. PubMed ID: 4688035
    [No Abstract] [Full Text] [Related]

  • 39. Deoxypyrimidineuria in the course of chemotherapy in M. Hodgkin.
    Dientsbier Z, Buric L, Bechynĕ M, Kovaríková H, Foltýnová V, Mostecký H.
    Neoplasma; 1976 Mar; 23(6):645-65. PubMed ID: 1004661
    [Abstract] [Full Text] [Related]

  • 40. [After-care examinations in Hodgkin's disease. Internal medicine and chemotherapy].
    Deutsch E, Honetz N.
    Fortschr Geb Rontgenstr Nuklearmed; 1973 Mar; 0(0):suppl:120-3. PubMed ID: 4135457
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.